Physician profile
Devin Eckhoff
NPI 1033152160
$4,379.17
in general payments reported to CMS, 2019-2025
7 companies · $2,088 in 2025
The $2,088 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $92.01 · 2023: $439 · 2024: $1,621 · 2025: $2,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,060 · Education: $1,500 · Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,059.89 |
| Education | $1,500.00 |
| Food and Beverage | $587.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,464.14 | 2019-2025 | |
| Transmedics, INC. | $439.00 | 2023 | Organ Care System |
| Boston Scientific Corporation | $145.82 | 2025 | Axios |
| Gilead Sciences, INC. | $122.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $116.09 | 2025 | |
| United Therapeutics Corporation | $92.01 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Eckhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.